This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
May 04, 2020
Nordic Nanovector Announces Changes to its Executive Management Team
May 04, 2020
Vicore offers advance voting in connection with the 2020 AGM
May 04, 2020
Targovax releases update for mesothelioma trial combining ONCOS-102 and chemotherapy
April 30, 2020
Targovax ASA appoints Dr Victor Levitsky as Chief Scientific Officer
April 29, 2020
BONESUPPORT HOLDING AB (publ) – Interim Report Q1 2020 – invitation to conference call and webcast
April 29, 2020
BONESUPPORT appoints Michael Roth as General Manager & Executive Vice President Commercial Operations North America
April 29, 2020
Targovax ASA: Invitation to online presentation of Targovax’s first quarter 2020 results, Thursday 7 May
April 28, 2020
Oncopeptides Annual Report 2019
April 28, 2020
Interim Report Q1 2020
April 28, 2020
Vicore Pharma gets regulatory approval to start phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 infection